MedKoo Cat#: 530499 | Name: GRI918013

Description:

WARNING: This product is for research use only, not for human or veterinary use.

GRI918013 is a ATX inhibitor. Autotaxin (ATX) inhibitors represent an emerging class of drug candidates with therapeutic potential in the treatment of disease conditions that include cancer, cardiovascular disease, chronic inflammation, and neuropathic pain.

Chemical Structure

GRI918013
GRI918013
CAS#313685-55-1

Theoretical Analysis

MedKoo Cat#: 530499

Name: GRI918013

CAS#: 313685-55-1

Chemical Formula: C17H15Cl2FN2O4S

Exact Mass: 432.0114

Molecular Weight: 433.28

Elemental Analysis: C, 47.13; H, 3.49; Cl, 16.36; F, 4.38; N, 6.47; O, 14.77; S, 7.40

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
GRI918013; GRI-918013; GRI 918013.
IUPAC/Chemical Name
2,4-dichloro-N-(3-fluorophenyl)-5-(morpholinosulfonyl)benzamide
InChi Key
WFSFEJJQFJYRFU-UHFFFAOYSA-N
InChi Code
InChI=1S/C17H15Cl2FN2O4S/c18-14-10-15(19)16(27(24,25)22-4-6-26-7-5-22)9-13(14)17(23)21-12-3-1-2-11(20)8-12/h1-3,8-10H,4-7H2,(H,21,23)
SMILES Code
O=C(NC1=CC=CC(F)=C1)C2=CC(S(=O)(N3CCOCC3)=O)=C(Cl)C=C2Cl
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info
Modulation of autotaxin (ATX), the lysophospholipase D enzyme that produces lysophosphatidic acid, with small-molecule inhibitors is a promising strategy for blocking the ATX-lysophosphatidic acid signaling axis.

Preparing Stock Solutions

The following data is based on the product molecular weight 433.28 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1. Fells, James I.; Lee, Sue Chin; Norman, Derek D.; Tsukahara, Ryoko; Kirby, Jason R.; Nelson, Sandra; Seibel, William; Papoian, Ruben; Patil, Renukadevi; Miller, Duane D.; et al. Targeting the hydrophobic pocket of autotaxin with virtual screening of inhibitors identifies a common aromatic sulfonamide structural motif. FEBS Journal (2014), 281(4), 1017-1028. 2. Fells, James I.; Lee, Sue Chin; Fujiwara, Yuko; Norman, Derek D.; Lim, Keng Gat; Tsukahara, Ryoko; Liu, Jianxiong; Patil, Renukadevi; Miller, Duane D.; Kirby, R. Jason; et al. Hits of a high-​throughput screen identify the hydrophobic pocket of autotaxin​/lysophospholipase D as an inhibitory surface. Molecular Pharmacology (2013), 84(3), 415-424.